Phase I Treatment of Adults With Primary Malignant Glioma With Topotecan (NSC #609699) Plus BCNU (NSC #409962).

Trial Profile

Phase I Treatment of Adults With Primary Malignant Glioma With Topotecan (NSC #609699) Plus BCNU (NSC #409962).

Completed
Phase of Trial: Phase I

Latest Information Update: 19 Feb 2013

At a glance

  • Drugs Carmustine (Primary) ; Topotecan (Primary)
  • Indications Glioma
  • Focus Adverse reactions
  • Most Recent Events

    • 16 Dec 2011 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently' (last verified Apr 2003).
    • 13 Dec 2011 Additional lead trial centre and investigator identified as reported by ClinicalTrials.gov.
    • 11 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top